x
0 Activities
0 Activities
No Saved Activities
Please wait
Home
Education
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
Search Education
Register
Contact Us
Login
Login
Remember Me
Log in
Create an account
Forgot your password?
Search
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
All France Foundation Content
Credit Type
Format
Credits
Specialty Area
Allergy/Clinical Immunology
Hepatology
Blood Management
Cardiology
Dermatology
Endocrinology
Epileptology
Family Medicine
Gastroenterology
Genetic Counselor
Genomic Medicine
Hematology
Hospice/Palliative Care
Hospitalist
Internal Medicine
Medical Laboratory Scientist
Neonatal/Perinatal
Neurology
Neuromuscular Specialist
Neuropsychology
Neurosurgery
Nurse
Nurse Practitioner
Nutrition
Ob/Gyn & Women's Health
Occupational Therapy
Oncology
Opthalmology
Orthopedic Surgery
Pediatrics
Pharmacist
Physical Medicine & Rehabilitation
Physician Assistant
Psychiatry/Mental Health
Pulmonary
Radiology
Rheumatology
Disease Area
Start
«
1
2
3
4
5
6
7
»
End
Page 6 of 7
Results 376 - 450 of 457
15
30
60
75
150
Gene Abnormalities and ILD
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
Updates on Registry Enrollment and Growth of the Care Center Network
New Approaches to the Diagnosis of IPF
Exploring New Therapeutic Avenues for Managing PF
New Research on Mechanisms in the Development of PF
Biosimilars: The New Era of Gastroenterology Management Considerations
Know Before You Go: IPF Grand Rounds Pre-learning
IPF Management Considerations
Perspectives on Side Effect Management
The Latest in IPF: Implications for Clinical Practice
Registry Data Provide Important Severity Indicators for PH
New Developments in the Diagnosis and Management of IPF
Palliative Care for Patients with IPF
Real World Experience in Patients with COPD
ICD-10 Codes and Nomenclature for Classification of PAH
Fleischner Society Update in Classification of IPF
Transbronchial Cryobiopsy for the Diagnosis of ILD
Psoriasis Management Considerations: What Would You Do?
Jamie Develops Complications with Her Psoriasis
Psoriasis: Three Case Studies in the Primary Care Setting
Cindy Has a Complex Case of Psoriasis
Optimizing Patient Outcomes in IPF
Understanding IPF as a Part of the Overall Scope of ILD
Famous People with Diabetes: Ella Fitzgerald
Famous People with Diabetes: Jerry Garcia
Targeting B-cells in Primary Progressive MS (PPMS)
Comorbidities and Selection of DMTs
The Gut Microbiota in MS
Early MS: Induction Therapy and Escalation Strategies
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options
The Importance of Early Referral and Treatment
How to Recognize and Diagnose IPF
What Is IPF?
What’s Next for IPF Therapy?
Applying the Evidence on Antifibrotic Agents for IPF
What Do the Experts Say about New Developments in the Diagnosis of ILD?
Is the delivery system a good match for your patients with COPD?
Stepping up or stepping down – which direction for COPD patients?
What’s the 2017 GOLD standard for managing patients with COPD?
UIP, IPF, NSIP, CHP: Making Sense of the Letters
Download Slides: Advancing T2DM Therapy with Confidence
Getting to Goal Can Be Difficult: Louise
Getting to Goal Can Be Difficult: Brian
A Personalized Approach to Managing Patients with Uncontrolled Asthma
Considering Biosimilars in Patients Failing their Initial Biologic
When to Switch? Biologically Experienced Patients with Spondyloarthritis
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
Innovator or Biosimilar for a Patient with Ulcerative Colitis?
Switching Between Biologics: Is a Biosimilar an Option?
When to Switch? Biologically Experienced Psoriasis Patients
Innovator or Biosimilar for a Patient with Psoriasis
Interchangeability and Pharmacy-Level Substitution
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
What is the Difference Between a Biosimilar and a Generic?
What is a Biologic?
New Strides in EGFR Inhibition for Non–Small Cell Lung Cancer
Pete - Work-Up of a Patient with Right Upper Lobe Mass and Metastases
Carl - High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy
Are You Ready to Use Biosimilars in Your Practice?
Radiologic Features of IPF
Gwen: A lawyer with a history of MI has a dry cough and trouble with stairs
Elizabeth: Loves the outdoors but bothered by persistent cough and GERD
Toni: Too tired to continue teaching and experiencing painful heartburn
Individualizing Patient Education in Treatment Choice: Practical Strategies
Biosimilars in Clinical Practice: Interchangeability and Extrapolation
Individualizing Patient Education in Treatment Choice: Practical Strategies
Addressing Common Barriers to Adherence
Discovering New Drugs for IPF
Biomarkers for IPF
New Trends in IPF
New Trends in IPF
Start
«
1
2
3
4
5
6
7
»
End
Page 6 of 7
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA
Search
Home
Education
Register
Contact Us
Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept